Literature DB >> 9748535

Physiological regulation of eukaryotic topoisomerase II.

R J Isaacs1, S L Davies, M I Sandri, C Redwood, N J Wells, I D Hickson.   

Abstract

Topoisomerase II is an essential enzyme in all organisms with several independent roles in DNA metabolism. In this article we review our knowledge on the regulation of the expression and catalytic activity of topoisomerase II in both lower and higher eukaryotes. Current data indicate that the regulation of topoisomerase II gene expression is complex, with positive and negative controls in evidence at the level of both promoter activity and mRNA stability. Similarly, the activity of the mature enzyme can be regulated by the action of several different protein kinases. Of particular interest is the cell cycle-dependent phosphorylation of topoisomerase II, including multiple, mitosis-specific modifications, which are proposed to regulate the essential chromosome decatenation activity of the enzyme.

Mesh:

Substances:

Year:  1998        PMID: 9748535     DOI: 10.1016/s0167-4781(98)00131-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  57 in total

1.  Sp1 mediates cell proliferation-dependent regulation of rat DNA topoisomerase IIalpha gene promoter.

Authors:  J H Yoon; J K Kim; G B Rha; M Oh; S H Park; R H Seong; S H Hong; S D Park
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

2.  Repression of CDK1 and other genes with CDE and CHR promoter elements during DNA damage-induced G(2)/M arrest in human cells.

Authors:  C Badie; J E Itzhaki; M J Sullivan; A J Carpenter; A C Porter
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

3.  A bromodomain protein, MCAP, associates with mitotic chromosomes and affects G(2)-to-M transition.

Authors:  A Dey; J Ellenberg; A Farina; A E Coleman; T Maruyama; S Sciortino; J Lippincott-Schwartz; K Ozato
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

4.  Influence of cell cycle and oncogene activity upon topoisomerase IIalpha expression and drug toxicity.

Authors:  D W Stacey; M Hitomi; G Chen
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

5.  Modulation of DNA topoisomerase II alpha promoter activity by members of the Sp (specificity protein) and NF-Y (nuclear factor Y) families of transcription factors.

Authors:  Natisha Magan; Agnieszka P Szremska; Richard J Isaacs; Kathryn M Stowell
Journal:  Biochem J       Date:  2003-09-15       Impact factor: 3.857

Review 6.  Expression of CDK8 and CDK8-interacting Genes as Potential Biomarkers in Breast Cancer.

Authors:  Eugenia V Broude; Balázs Győrffy; Alexander A Chumanevich; Mengqian Chen; Martina S J McDermott; Michael Shtutman; James F Catroppo; Igor B Roninson
Journal:  Curr Cancer Drug Targets       Date:  2015       Impact factor: 3.428

7.  Impact of the C-terminal domain of topoisomerase IIalpha on the DNA cleavage activity of the human enzyme.

Authors:  Jennifer S Dickey; Neil Osheroff
Journal:  Biochemistry       Date:  2005-08-30       Impact factor: 3.162

8.  The geometry of DNA supercoils modulates topoisomerase-mediated DNA cleavage and enzyme response to anticancer drugs.

Authors:  A Kathleen McClendon; Neil Osheroff
Journal:  Biochemistry       Date:  2006-03-07       Impact factor: 3.162

9.  Tyrosine 656 in topoisomerase IIβ is important for the catalytic activity of the enzyme: Identification based on artifactual +80-Da modification at this site.

Authors:  Adrian G Grozav; Belinda B Willard; Toshiyuki Kozuki; Kenichi Chikamori; Marius A Micluta; Andrei-Jose Petrescu; Michael Kinter; Ram Ganapathi; Mahrukh K Ganapathi
Journal:  Proteomics       Date:  2011-01-31       Impact factor: 3.984

Review 10.  Iron chelators with topoisomerase-inhibitory activity and their anticancer applications.

Authors:  V Ashutosh Rao
Journal:  Antioxid Redox Signal       Date:  2012-10-26       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.